Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XCVEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCVEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCVENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCVENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.31.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.31.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.31.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.31.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.31.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.31.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.31.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.31.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.50EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.50ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.50ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.50EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.50EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.50ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.78EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.78EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.78ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.78ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.78EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.78EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.78ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.78ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.15ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.15EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.24ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.24ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.24EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.24EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.236EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.236EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.236ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.236ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.236EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.236EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.236ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.236ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.153EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used